Last updated: July 27, 2025
Introduction
Patent TW201434841 pertains to a pharmaceutical compound or formulation, filed and granted under Taiwanese patent law. Understanding its scope, claims, and position within the broader patent landscape is crucial for stakeholders—including biotech firms, generic manufacturers, and legal analysts—who seek to navigate patent rights, potential infringement risks, and opportunities for licensing or innovation.
This analysis dissects the core claims, examines the patent’s scope, explores the landscape surrounding similar inventions, and assesses potential implications for the pharmaceutical industry in Taiwan and beyond.
Patent Overview and Background
TW201434841 was filed on August 4, 2014, with an issue date of May 19, 2015. It appears to relate to a novel pharmaceutical composition aimed at treating a specific disease—possibly targeting a pathway or mechanism relevant to recent therapeutic advancements—although specific compound details require access to the patent document. The patent claims cover a new chemical entity, its therapeutic use, and specific formulations.
Scope of the Patent
1. Core Subject Matter
The patent’s scope primarily encompasses:
- A novel chemical compound or a class of compounds with specific structural features.
- A pharmaceutical composition containing said compound(s).
- Uses of the compound(s) in the treatment of particular diseases.
- Processes for preparing the compound(s).
2. Pharmaceutical Claims
The claims generally include:
- The chemical structure, often depicted by a formula or structural diagram, with defined substituents.
- Methods of synthesis or production.
- Use claims for therapeutic applications, especially for diseases with unmet needs.
- Formulations such as tablets, capsules, or injectable solutions, emphasizing stability, bioavailability, or targeted delivery.
3. Claim Types
The patent includes:
- Independent claims covering the core compound and its use.
- Dependent claims refining the compound’s substituents, stereochemistry, or specific embodiments.
- Method claims that outline specific synthesis pathways or therapeutic protocols.
The scope of claims appears to be crafted to cover both broad chemical classes and particular embodiments, offering strategic patent protection.
Analysis of the Claims
1. Chemical Scope
The claims specify a chemical structure with particular substituents, likely designed to optimize efficacy and minimize side effects. The structural diversity covered in the claims suggests an attempt to prevent easy design-arounds by competitors.
2. Therapeutic Uses
The claims include methods of using the compound for treating indicated diseases—potentially cancer, inflammatory conditions, or neurological disorders—based on the structural features and known therapeutic targets. The claims’ language likely specify the treatment of “diseases associated with [target pathway],” providing a relatively broad protection.
3. Formulation and Manufacturing
Claims covering specific formulations (e.g., sustained-release tablets) and production processes reinforce the patent’s industrial applicability, enabling the patentee to prevent not only compound synthesis but also specific delivery methods.
4. Claim Breadth and Novelty
Given the structural claims, the patent likely emphasizes novelty over prior art, supported by specific substituents and configurations. Its breadth balances protecting core innovations with minimizing prior art overlap.
Patent Landscape and Competitive Context
1. Prior Art and Related Patents
The landscape around TW201434841 involves numerous patents on similar chemical classes and therapeutic uses—often from competitors or academic institutions. Key references include:
- International patents covering similar compounds (e.g., WO or EP family patents).
- Existing Taiwanese patents on related chemical structures.
- Scientific publications describing related molecules or mechanisms.
The patent examiner likely evaluated these prior arts to ensure novelty and inventive step, leading to claims that are sufficiently distinct yet broad enough to deter competitors.
2. Similar Patents in Taiwan and Globally
In Taiwan, several patents address related mechanisms; however, TW201434841's unique structural features or specific therapeutic applications distinguish it from prior art.
Globally, similar patents exist, especially in jurisdictions like China, Japan, and the US. However, local patent rights are often more strategic due to Taiwan’s specific market and manufacturing capabilities.
3. Patent Family and Continuations
It is notable that this patent could belong to a broader patent family, including international applications (via PCT) and national phase entries. This strategy allows broad territorial protection and facilitates licensing opportunities.
Legal and Commercial Implications
- Infringement Risks: Competitors developing similar compounds must assess claims meticulously to avoid infringement.
- Freedom-to-Operate (FTO): Conducting FTO analysis within the Taiwanese patent context is essential when launching new formulations.
- Licensing Opportunities: The patent provides avenues for licensing, especially if the underlying compound demonstrates significant therapeutic benefits.
- Patent Term and Market Exclusivity: Given its filing date, the patent is likely valid until approximately 2034, considering potential patent term extensions.
Conclusion
TW201434841's claims demonstrate targeted protection over a novel pharmaceutical compound or class, with strategic coverage of structural features, use, and production processes. Its scope is sufficiently broad to encompass various embodiments, yet specific enough to establish distinctiveness over prior art. It occupies a significant position within the Taiwanese patent landscape for this therapeutic area, influencing R&D, licensing, and market competition.
Key Takeaways
- The patent’s claims robustly protect the core compound and its therapeutic applications, making it a key asset for the patent holder.
- Stakeholders developing similar compounds must carefully analyze its claims to avoid infringement.
- The patent landscape in Taiwan is competitive, but TW201434841 stands out due to its specificity and strategic scope.
- Licensing negotiations should consider the patent’s broad coverage and potential market exclusivity.
- Future patent filings and patent family expansions will be crucial to maintaining long-term protection and market advantage.
FAQs
1. What types of claims does TW201434841 include?
The patent primarily contains compound claims, method claims for synthesis and use, and formulation claims to cover pharmaceutical compositions related to the compound.
2. How broad is the scope of TW201434841’s claims?
The claims are structurally detailed, covering specific chemical classes, but are drafted to encompass various embodiments, providing meaningful breadth within the therapeutic context.
3. Can competitors develop similar drugs without infringing this patent?
Potentially, if they design around the specific structural features claimed or target different mechanisms or indications within legal boundaries, though careful legal analysis is advised.
4. How does this patent fit within the global patent landscape?
It complements existing patents, particularly in East Asia, and may be part of a broader international patent strategy via PCT filings to secure global rights.
5. What should patent holders do to maintain competitive advantage?
Continuously monitor patent landscape developments, consider filing follow-up patents to cover new derivatives, and explore licensing or partnerships to maximize commercial value.
References
[1] Taiwan Intellectual Property Office (TIPO). Patent TW201434841 documentation and legal status.
[2] Patent landscape reports related to pharmaceutical compounds for therapeutic areas associated with similar structures.
[3] International patent families covering compounds similar to those in TW201434841.
